ghrp-2 vs ghrp-6: Frequently asked questions

Increase GHRP-2 dosing to 200–250 mcg per administration to match GHRP-6's peak GH amplitude while avoiding ghrelin-driven food intake increases. This approach is standard in body composition studies where caloric intake must remain constant to isolate GH's direct lipolytic and anabolic effects. Labs using this strategy report GH peaks of 8–10 ng/mL with GHRP-2 at 250 mcg. Functionally equivalent to GHRP-6 at 150 mcg. But without the 40–60% post-dose feeding response.

Switch to GHRP-2 or implement structured feeding windows that account for GHRP-6's orexigenic response. Three-times-daily GHRP-6 administration produces sustained ghrelin receptor activation that can drive 15–25% increases in daily caloric intake, confounding metabolic endpoints. GHRP-2 eliminates that cumulative effect entirely.

GHRP-6 is the mechanistically appropriate choice when the hypothesis involves appetite modulation, energy balance, or metabolic adaptations driven by ghrelin signalling. Studies examining how GH and ghrelin together influence lean mass accrual during caloric restriction require GHRP-6's dual-pathway activation. GHRP-2 would fail to model the ghrelin component, rendering those findings incomplete.

GHRP-6 is the correct choice. Its non-selective ghrelin receptor binding allows direct investigation of peripheral ghrelin effects including appetite regulation, gastric motility, and NPY cascade activation. GHRP-2's selectivity for GHS-R1a means it bypasses many peripheral ghrelin pathways, making it unsuitable for studies targeting ghrelin's role in hunger, digestion, or metabolic signaling outside the pituitary.

GHRP-2 produces 60–70% less cortisol co-secretion than GHRP-6 at matched doses. Switch to GHRP-2 if your protocol examines immune function, sleep quality, or muscle protein synthesis, all of which are suppressed by elevated cortisol. GHRP-6's cortisol spike disrupts circadian rhythm studies and introduces inflammation markers that mask primary outcomes in immune response research.

Use GHRP-2 exclusively. GHRP-6's ghrelin pathway activation will increase food intake and introduce an uncontrolled variable. GHRP-2 delivers equivalent GH pulses without the appetite spike, preserving stable caloric intake baselines critical to metabolic or body composition studies. Protocols examining fat oxidation, insulin sensitivity, or lean mass retention cannot tolerate the confounding hunger effect GHRP-6 produces.